ROCHE-BM18249



A Randomized Double-blind Study to Determine the Effect of GK Activator (2) on Efficacy (HbA1c), Safety, Tolerability and Pharmacokinetics in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin.
GK Activator (2)
BM18249
NCT00266253
Type 2 Diabetes Mellitus
Phase 2
 
October 2016